Joseph William Stauffer

Joseph William Stauffer discloses dealings in Tvardi Therapeutics, Inc. to SEC (Form 4). We count 4 filings; the first trade dates from 1 December 2014 and the latest from 17 October 2018.

Market trades split into 1 purchase (€34k) and 2 sales (€200k). Taken together, the sales exceed the purchases by €166k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant. In 2018 alone, the filings show no purchases and 2 sales.

The record was last updated on 19 October 2018 with an open-market sale (€183k) in Tvardi Therapeutics, Inc. The last insider purchase was made public on 6 August 2015, 4,113 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.